跳至主要内容
临床试验/NCT00415402
NCT00415402已完成不适用

Randomised Controlled Trial to Evaluate the Preventive Effect on Mortality and Serious Morbidity/ Hospitalisations of Daily Vitamin D Supplements in Small for Gestational Age Term Infants

Delhi University1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2007年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,000
试验地点
1
主要终点
Mortality

研究概览

简要总结

The purpose of this study is to determine whether a weekly supplement of vitamin D to low birth weight term infants will reduce their mortality and hospital admissions and improve their immunity.

详细描述

We are conducting a randomised controlled trial of weekly oral vitamin D supplements to low birth weight (< 2.5 kg) term infants born in a large government hospital catering to a low-middle income population in Delhi. Mothers and infants are recruited at delivery and given weekly vitamin D supplements or placebo until 6 months of age. Data on infant morbidity, sun exposure and diet, with particular emphasis on breast milk and other milk intake, is collected by fieldworkers visiting the homes each fortnight. Mothers are encouraged to bring their infants to the hospital in case of any illness and at these visits the infant is seen by the project doctor who treats the infant and records additional morbidity data. At 6 months blood samples are being collected from a 20% random subsample of infants for measurement of 25OHD and indicators of immune activation. The primary outcome is mortality or incidence of any illness requiring admission to hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
24 Hours 至 2 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Born at term, as determined from last menstrual period
  • Weighing < 2.5 kg
  • Resident within 12 km of the hospital and expected to continue living in the area for the following 6 months
  • With no severe congenital abnormalities
  • No morbidity severe enough to be expected to result in death before 7 days due to severe respiratory distress, shock, pulmonary sepsis, etc.
  • Parental informed consent

排除标准

  • 未提供

研究组 & 干预措施

Vitamin D3

Experimental

vitamin D granules

干预措施: Vitamin D3 (Drug)

结局指标

主要结局

Mortality

时间窗: weekly

Incidence of disease requiring hospitalization

Morbidity and hospitalization

时间窗: weekly

次要结局

  • Incidence of infectious disease not requiring hospitalization
  • Severe morbidity requiring hospitalization

研究者

发起方
Delhi University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Geeta Trilok-Kumar

Associate professor

Delhi University

研究点 (1)

Loading locations...

相似试验